WBJournal

Harvard Bioscience Inc.

Holliston biotechnology firm Harvard Bioscience continued its fourth quarter momentum with revenue up 14% in the first quarter of 2021 when compared to the first quarter of 2020. Holliston ...
Nasdaq

Examining the Future: Harvard Bioscience's Earnings Outlook

Harvard Bioscience (NASDAQ:HBIO) is set to give its latest quarterly earnings report on Monday, 2025-05-12. Here's what investors need to know before the announcement. Analysts estimate that Harvard ...
Yahoo Finance

Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package

HOLLISTON, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”), today announced it ...
Seeking Alpha

Harvard Bioscience: Looking To Reload After Post-Q2 Earnings Sell-Off

Harvard Bioscience's Q2 earnings showed a slight miss on EPS and revenue, causing a decline in the stock price. The company is committed to improving its product portfolio and has observed increased ...
The National Law Review

Harvard Bioscience Announces CFO Transition

HOLLISTON, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Jennifer Cote, the Company’s Chief Financial Officer and ...
Nasdaq

Harvard Bioscience, Inc. to Announce Q1 2025 Financial Results on May 12, 2025

Harvard Bioscience, Inc. (Nasdaq: HBIO) will release its financial results for the first quarter of 2025 on May 12, 2025, before the market opens, followed by a conference call at 8:00 a.m. Eastern ...
Seeking Alpha

Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board

Current Board member John Duke to succeed Jim Green as President & CEO Rob Gagnon and Seth Benson appointed as new Board members Q2 ’25 revenue anticipated to be $20.4 million and Company reiterates ...
Hosted on MSN

Harvard Bioscience outlines Q2 revenue target of $18M–$20M amid product launches and cost actions

Green stated, "With uncertainty around NIH and academic research funding and the China tariff situation, we now expect second quarter revenue in the range of $18 million to $20 million and we expect ...
Twin Cities Business

Data Sciences International Selling for $70 Million

Harvard Bioscience Inc., a publicly-traded company based in Holliston, Massachusetts, has struck a deal to acquire New Brighton-based Data Sciences International for approximately $70 million. The ...
MarketWatch

Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States

The MarketWatch News Department was not involved in the creation of this content. HOLLISTON, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the "Company" or ...
Business Insider

Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors

HOLLISTON, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”) today announced the appointment of Stephen DeNelsky to its Board of ...
WBJournal

Harvard Bioscience Inc.

Jim Green will retire from his roles as chairman, president, and CEO of Harvard Bioscience on July 28. Harvard Bioscience falls out of Nasdaq compliance after board member resignation Harvard ...